Ftse Mib
35.393,45
-0,05%
DAX
18.716,94
-0,05%
S&P 500
5.295,22
-0,04%
NASDAQ
16.702,85
0,03%
Bitcoin
67.273,07
3,13%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX IsoRay Inc (ISR) IsoRay Inc (ISR) Notizie

ISR

IsoRay (ISR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:ISR
DataOraFonteTitoloSimboloCompagnia
15/05/202413:02Edgar (US Regulatory)Form 8-K - Current reportAMEX:ISRIsoRay Inc
24/04/202422:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ISRIsoRay Inc
19/04/202422:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:ISRIsoRay Inc
18/04/202422:11Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:ISRIsoRay Inc
18/04/202422:09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:ISRIsoRay Inc
10/04/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:ISRIsoRay Inc
09/04/202422:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:ISRIsoRay Inc
08/04/202422:12Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:ISRIsoRay Inc
01/04/202413:46Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:ISRIsoRay Inc
29/03/202412:35Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:ISRIsoRay Inc
28/03/202413:34Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:ISRIsoRay Inc
18/03/202421:18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:ISRIsoRay Inc
08/03/202417:22Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:ISRIsoRay Inc
06/02/202401:18Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:ISRIsoRay Inc
01/02/202413:56Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:ISRIsoRay Inc
01/02/202413:38Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipAMEX:ISRIsoRay Inc
18/01/202422:49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:ISRIsoRay Inc
17/01/202419:40Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]AMEX:ISRIsoRay Inc
14/11/202322:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:ISRIsoRay Inc
14/06/202322:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ISRIsoRay Inc
14/06/202322:42Edgar (US Regulatory)Specialized Disclosure Report (sd)AMEX:ISRIsoRay Inc
15/05/202323:23Edgar (US Regulatory)Quarterly Report (10-q)AMEX:ISRIsoRay Inc
15/05/202323:16Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ISRIsoRay Inc
01/05/202323:04Edgar (US Regulatory)Annual Transition Report (10-kt)AMEX:ISRIsoRay Inc
17/03/202322:09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ISRIsoRay Inc
08/03/202313:30GlobeNewswire Inc.Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King’s College London to Support Radiobiology Research of Alpha Particle Therapy for CancerAMEX:ISRIsoRay Inc
22/02/202323:02GlobeNewswire Inc.Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific SessionAMEX:ISRIsoRay Inc
21/02/202312:02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ISRIsoRay Inc
16/02/202322:05GlobeNewswire Inc.Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022AMEX:ISRIsoRay Inc
07/02/202323:48GlobeNewswire Inc.Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.AMEX:ISRIsoRay Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:ISR

La tua Cronologia

EU
ALHYP
Hipay
DGFX
YGGUSDT
Yield Guild Games Token
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network